Benchmark Holdings PLC (LSE:BMK) - Share price


Stock Report

Benchmark Holdings PLC BMK

Last Price
GBX41.00

Day Change
0.00|0.00%

As of 17/06/2019
14:56:40 BST | GBX
Minimum 15 Minutes Delay.

Last Close41.00p
Day Range40.00 - 41.45
Mkt Cap228.80Mil
52-Wk Range39.00 - 66.00
Yield %-
ISINGB00BGHPT808
Volume55,397
P/E-54.59
P/S0.01
P/CF-0.58

Share Price

Total Returns 14/06/2019

 Chg (%)  
More ...
Benchmark Holdings PLC-8.89 
FTSE 100 TR GBP2.04
 
Financials
201620172018
More ...
Income Statement
Turnover109.38140.17151.47
Operating Profit-7.53-13.31-7.46
Net Profit-18.35-7.12-4.39
Reported EPS-4.39-1.43-0.94
Balance Sheet
Current Assets102.4988.1697.80
Non Current Assets408.42418.48455.05
Total Assets510.91506.64552.85
Current Liabilities33.7154.0349.28
Total Liabilities---
Total Equity367.70358.59381.85
Cash Flow
Operating Cash Flow-9.1016.392.16
Net Change in Cash24.58-19.364.86
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
10/12/2018PurchaseMr. Yngve Myhre57.50100,00057,500.00
09/10/2018PurchaseHugo Wahnish56.50100,00056,500.00
20/06/2018PurchaseHugo Wahnish0.87100,00087,090.00
19/06/2018PurchaseHugo Wahnish0.8525,00021,120.00

Company Profile

Benchmark Holdings PLC is a drug manufacturer in the United Kingdom. The company caters particularly aquaculture industry with its products such as animal health vaccines, medicines, biocides and diagnostics.

Sector

Drug Manufacturers - Specialty & Generic

Index

FTSE AIM 100 ,FTSE AIM All-Share

Next Event 25/06/2019

Half-Yearly Results
Ratios
Comp
More ...
PER (E)0.00
Div Yld (E)0.00
PEG (E)0.00
ROCE-2.23
Op Mrgn-0.05
EPS Grwth0.00
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
Directors
More ...
Non-Executive DirectorMs. Susan Jane Searle
Non-Executive DirectorMr Kevin Quinn
Executive Director, Chief Executive OfficerMr. Malcolm David Foster Pye
Executive Director, Chief Financial OfficerMr. Mark James Plampin
Non-Executive DirectorMr. Yngve Myhre
Non-Executive DirectorHugo Wahnish
Executive Director, Chief Scientific OfficerAlexander Josef Raeber
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2019 Morningstar. All rights reserved.